𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenotypic analyses of lymphokine-activated killer cells that release interferon γ and tumor necrosis factor α

✍ Scribed by Anita S. -F. Chong; Belen Ybarrondo; William J. Grimes; Evan M. Hersh; Philip Scuderi

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
682 KB
Volume
31
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytolysis of malignant glioma cells by l
Cytolysis of malignant glioma cells by lymphokine-activated killer cells combined with anti-CD3/antiglioma bifunctional antibody and tumor necrosis factor-α
✍ Yoshida, Jun; Takaoka, Toru; Mizuno, Masaaki; Momota, Hiroshi; Okada, Hidechika 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

With the aim of developing an effective immunotherapy for malignant glioma, glioma cells were incubated with tumor necrosis factor-a (TNF-a) to increase their susceptibility to lysis by lymphokine-activated killer (LAK) cells. Treatment with exogenous TNF-a induced the expression of intercellular ad

Induction of transcription factor interf
Induction of transcription factor interferon regulatory factor-1 by interferon-γ (IFNγ) and tumor necrosis factor-α (TNFα) in FRTL-5 cells
✍ Kouki Mori; Scott Stone; Lalita Khaodhiar; Lewis E. Braverman; William J. DeVito 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

While it is well known that interferon-␥ (IFN␥) and tumor necrosis factor-␣ (TNF␣) play a role in the regulation of thyroid growth and differentiated functions, the cellular and molecular mechanisms involved in mediating the effects of IFN␥ and TNF␣ on thyroid function are unknown. In the present st

Anti-parasitic effector mechanisms in hu
Anti-parasitic effector mechanisms in human brain tumor cells: Role of interferon-γ and tumor necrosis factor-α
✍ Walter Däubener; Christine Remscheid; Susanne Nockemann; Korinna Pilz; Samira Se 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Toxoplasrna gondii, an obligate intracellular parasite, is able to replicate in human brain cells. We recently showed that interferon (1FN)-y-activated cells from glioblastoma line 86HG39 were able to restrict Toxoplusma growth. The effector mechanism responsible for this toxoplasmostatic effect was